Skip to main content
. Author manuscript; available in PMC: 2012 Apr 19.
Published in final edited form as: Int J Oncol. 2011 Apr 21;39(1):111–119. doi: 10.3892/ijo.2011.1014

Figure 2.

Figure 2

Both TSA and valproic acid impair cell viability of VCaP cells. (A) Cells were treated with variable amount of valproic acid (0.05–20 mM) or vehicle control for 24, 48, or 72 h. (B) Cells were treated with variable amount of trichostatin-A (10–200 nM) or vehicle control for 24, 48, or 72 h. Results are shown as the mean of percentage of control of three independent experiments with standard deviations.

HHS Vulnerability Disclosure